IUG
NEUTRALIntelligent Ultrasound Group Announces Change in Major Shareholding
The healthcare technology company has announced a change in major shareholding, as required by regulations.
IUG
0.00%
Market Cap
Volume
0
NaN% of avg
P/E Ratio
N/A
EPS (TTM)
N/A
Beta
N/A
Day Range
p - p
52 Week Range
N/AppN/Ap
p
No data available for this timeframe
IUG
NEUTRALIntelligent Ultrasound Group Announces Change in Major Shareholding
The medical device company has announced a change in major shareholding, with one investor reducing its stake.
IUG
NEUTRALIntelligent Ultrasound to be Acquired by Surgical Science in Court-Sanctioned Scheme
The medical device company has received court approval for its acquisition by Surgical Science, paving the way for the deal to complete.
IUG
NEUTRALIntelligent Ultrasound Group Announces Change in Major Shareholding
The medical technology company announces a change in major shareholding, with ODDO BHF AIF PUBLIC LIMITED COMPANY acquiring a 3.09% stake.
IUG
NEUTRALIntelligent Ultrasound Announces Change of Location for Shareholder Meetings
The healthcare company announces a change in location for its upcoming shareholder meetings, but the date and time remain unchanged.
IUG
NEUTRALIntelligent Ultrasound Issues New Shares Following Options Exercise
Ultrasound tech firm expands share count
IUG
NEUTRALIntelligent Ultrasound Completes Capital Reduction, Announces Trading Update
Medical device company Intelligent Ultrasound completes capital reduction, announces trading update with revenue decline
IUG
NEUTRALIntelligent Ultrasound Group Announces Exercise of Share Options
The medical technology company announces the exercise of 150,000 share options, resulting in the issuance of new ordinary shares.
IUG
GOODIntelligent Ultrasound Completes £40.5M Sale of Clinical AI Business to GE HealthCare
Medical simulation and AI software company completes £40.5M sale of its Clinical AI division to GE HealthCare, retaining its Simulation Business.
IUG
NEUTRALIntelligent Ultrasound Announces Capital Reduction Plan
Medical device company announces capital reduction plan, providing opportunity for shareholder returns.